CCM Duopharma Biotech Berhad (Duopharma), one of Malaysia’s leading pharmaceutical company, was established in 1979. Since then, it has grown to become one of Malaysia’s pioneers in the biosimilar industry – besides already being a leading manufacturer of generic medicines and branded consumer healthcare products in the country and in Asean.
A biosimilar product is also known as a “follow-on biologic” or “subsequent entry biologic” which is almost an identical copy of an original product which has been manufactured by a different company.
Following a demerger from CCM Berhad in December 2017, Duopharma attained a significant milestone in just 2018 alone, with its quest for new drugs and treatments.
